The supply chain network for cannabis and its derivatives was severely disrupted by the pandemic, and as a result of ongoing restrictions, shortages are also affecting government-authorized dispensaries. Nearly all commodities, whether they are necessary or not, have experienced changes in import and export. However, as a result of governments supporting legalisation, demand has increased and is anticipated to remain high for the foreseeable future. Instead of the previously prescribed medications, patients are choosing marijuana derivatives.
Due to ongoing restrictions, shortages are also affecting government-approved dispensaries. The pandemic severely disrupted the supply chain network for cannabis and its derivatives. Whether or not they are necessary, almost all commodities have seen changes in their import and export. Government support for legalisation has, however, increased demand, which is expected to stay high for the foreseeable future. Patients are choosing marijuana derivatives over the previously prescribed medications.
Since there are currently no federal laws allowing for the use of cannabis, despite previous surveys and studies showing a variety of medical uses, pharmacists are still wary of its use and avoid recommending it to patients for fear of breaking any laws. According to a 2019 survey by the California Pharmacists Association, more than 75% of pharmacists would think about discussing medical cannabis use with patients if the FDA approved it.
Cannabis legalisation is frequently viewed from two perspectives, and it has historically been greeted with suspicion due to concerns about potential abuse. People are now able to use drugs safely and recognise the medical benefits of cannabis thanks to its legalisation. Because of this, many nations are gradually legalising its use all over the world. Even though the majority of the world’s nations have not yet legalised recreational use, attitudes toward its use and sale have softened over time. This has caused its use to become more and more common, which is causing the global market to grow.
For More Insights Download Sample Copy of Legalized Cannabis Market
https://crediblemarkets.com/sample-request/legalized-cannabis-market-294005
Key players in the global Legalized Cannabis market
Canopy Growth Corporation
Aurora Cannabis Inc
HEXO Corp
Maricann Group, Inc
Stenocare A/S
CV Sciences
OrganiGram Holding Inc
Aphria, Inc.
Tilray, Inc.
The Green Organic Dutchman Holdings Ltd
Tikun Olam Ltd.
Cannabis Science, Inc
VIVO Cannabis Inc
Medical Marijuana, Inc
Terra Tech Corp
Cronos Group Inc.
on the basis of types, the Legalized Cannabis market
Buds / Cannabis Flower
Cannabis Extracts
on the basis of applications, the Legalized Cannabis market
Medical
Recreational
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in
North America
United States
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific
China
Japan
South Korea
Australia
India
South America
Brazil
Argentina
Columbia
Middle East and Africa
UAE
Egypt
South Africa
Click Here for Direct Purchase Legalized Cannabis Research Report:
Frequently Asked Questions About This Report
How big is the legal marijuana market?
What is the legal marijuana market growth?
Which type of legal marijuana led the global market?
Which product type dominated the legal marijuana market?
Which medical application accounted for the highest share in the legal marijuana market?
About Credible Markets:
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
The collection of market intelligence reports is regularly updated to offer visitors ready access to the most recent market insights. We provide round-the-clock support to help you repurpose search parameters and thereby avail a complete range of reserved reports. After all, it is all about helping you reach an informed strategic decision about purchasing the right report that caters to all your market research demands.
Reports in the repository of Credible Markets leverage predictive analytical models to study the performance of critical market segments. We believe in the fact that demands of businesses depend on an array of parameters and thus adhere to delivering industry-specific research solutions. Our client base traversing from thriving start-ups to some of the Fortune 500 companies speaks for our expertise in providing deep-dive insights on any desired industry sectors.
Contact US:
Credible Markets Analytics
99 Wall Street #2124 New York, NY 10005
+1(929)-450-2887
sales@crediblemarkets.com
